Integra LifeSciences Holdings Corp. is a healthcare company based in the United States specializing in regenerative therapy, extremity orthopedics, and neurosurgical applications. With a medium risk ESG score of 22.8, the company operates under two primary segments: Codman specialty surgical and tissue technologies. Integra generates significant revenue from its segmental operations and serves customers in Europe, Asia Pacific, and globally, with a focus on domestic sales.